Consideration of use of phenothiazines in particular trifluorperazine for epidermal growth factor receptor associated cancers
Authors:
- Eric Lewin AltschulerEAEric Lewin Altschuler
- 31 December 2007
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 69 (5) , 1074-1075
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumoursCancer Treatment Reviews, 2006
- Current Status of Cetuximab for the Treatment of Patients with Solid TumorsAnnals of Pharmacotherapy, 2006
- Imatinib as a Paradigm of Targeted Therapies2004
- Inhibition of epidermal growth factor‐induced phosphorylation by trifluoperazineJournal of Cellular Physiology, 1985
- Loss of α2‐macroglobulin and epidermal growth factor surface binding induced by phenothiazines and naphthalene sulfonamidesJournal of Cellular Physiology, 1984
- Inhibition of epidermal growth factor-induced mitogenesis in bovine granuldsa cells by trifluoperazineBiochemical and Biophysical Research Communications, 1981